BioCentury | Mar 16, 2009
Company News

Genavia Therapeutics Ltd., Origen Therapeutics Inc., Symphogen deal

...will receive an undisclosed equity stake in Genavia and is eligible for milestones and royalties. Genavia Therapeutics Ltd....
Items per page:
1 - 1 of 1
BioCentury | Mar 16, 2009
Company News

Genavia Therapeutics Ltd., Origen Therapeutics Inc., Symphogen deal

...will receive an undisclosed equity stake in Genavia and is eligible for milestones and royalties. Genavia Therapeutics Ltd....
Items per page:
1 - 1 of 1